DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies

DNA Repair (Amst). 2019 Aug:80:59-84. doi: 10.1016/j.dnarep.2019.06.005. Epub 2019 Jun 17.

Abstract

Ovarian cancer is among the most lethal gynecologic malignancies with a poor survival prognosis. The current therapeutic strategies involve surgery and chemotherapy. Research is now focused on novel agents especially those targeting DNA damage response (DDR) pathways. Understanding the DDR process in ovarian cancer necessitates having a detailed knowledge on a series of signaling mediators at the cellular and molecular levels. The complexity of the DDR process in ovarian cancer and how this process works in metastatic conditions is comprehensively reviewed. For evaluating the efficacy of therapeutic agents targeting DNA damage in ovarian cancer, we will discuss the components of this system including DDR sensors, DDR transducers, DDR mediators, and DDR effectors. The constituent pathways include DNA repair machinery, cell cycle checkpoints, and apoptotic pathways. We also will assess the potential of active mediators involved in the DDR process such as therapeutic and prognostic candidates that may facilitate future studies.

Keywords: DNA damage response; DNA repair; Ovarian cancer.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Cell Cycle Checkpoints*
  • DNA / metabolism
  • DNA Damage*
  • DNA Repair*
  • Female
  • Humans
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism*
  • Signal Transduction*

Substances

  • DNA